A pharmaceutical company conducts a study to evaluate the relationship between length of time taking drug X and size of tumor. They enlist 2,400 patients with the same type of benign tumor who have been on drug X for varying lengths of time (measured in days). They find that the longer the patient is on the drug, the smaller the patientâ€™s tumor size (measured in volume). In fact, they report the results as r(2398) = -.21, with significance of p < .0001. What is your initial perception of this information? What are other ways, beyond looking at the p-value alone, you could use to try to interpret what this outcome of r(2398) = -.21 tells us about the relationship between length of time taking drug X and the size of the tumor? Support your responses.
Please provide a 250 word response to the above question. Please also use at least 1 peer reviewed article as a reference and please list reference in paper in APA 6th edition format.